19例腮腺腺泡细胞癌的MRI影像表现分析

doi:10.19439/j.sjos.2022.03.020

上海口腔医学 ›› 2022, Vol. 31 ›› Issue (3): 322-326.doi: 10.19439/j.sjos.2022.03.020

19例腮腺腺泡细胞癌的MRI影像表现分析

肖华, 陶晓峰, 朱文静^*, 陈倩倩^*

上海交通大学医学院附属第九人民医院放射科,上海 200011

收稿日期:2022-01-17 修回日期:2022-03-01 出版日期:2022-06-25 发布日期:2022-07-07
通讯作者: 朱文静,E-mail：amanda_1983_328@163.com;陈倩倩,E-mail：chenqianqian0902@163.com。^*共同通信作者
作者简介:肖华（1986-）,女,硕士,住院医师,E-mail：jo.xiao@qq.com
基金资助:
国家自然科学基金（91859202、81771901）

MRI findings of parotid acinic cell carcinoma in 19 consecutive cases

XIAO Hua, TAO Xiao-feng, ZHU Wen-jing, CHEN Qian-qian

Department of Radiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai 200011, China

Received:2022-01-17 Revised:2022-03-01 Online:2022-06-25 Published:2022-07-07

摘要/Abstract

摘要： 目的: 总结腮腺腺泡细胞癌（acinar cell carcinoma,AciCC）的MRI特征,探讨MR功能成像的诊断价值。方法: 分析269例经手术病理证实的颌面部AciCC的临床资料。其中,19例腮腺AciCC行术前MRI检查（1例平扫,18例增强）,17例行DWI扫描, 15例行DCE扫描。回顾分析19例患者的MRI表现,分析病灶大小、部位、形态、边缘、内部结构、强化方式及功能成像特点。采用SPSS 25.0软件包对数据进行统计学分析。结果: 269例颌面部AciCC中,男108例,女161例,男∶女=1∶1.49。年龄4~89岁,平均年龄（45.95±17.33）岁。84.4%（227/269）的发病部位位于腮腺。MRI表现为78.9%（15/19）病变边界清晰,57.9%（11/19）呈圆形或椭圆形,36.8%（7/19）呈分叶状结节。1例病变形态不规则,且侵犯外周。病灶最大径6~56 mm,平均（24.8±15.3） mm。内部结构为57.9%（11/19）呈囊实性,42.1%（8/19）呈实性,31.6%（6/19）有出血。T2加权像52.6%（10/19）可见包膜结构,15.8%（3/19）内部见低信号分隔;38.9%（7/18）强化均匀,61.1%（11/18）强化不均匀。功能成像显示肿瘤平均ADC值为（1.026±0.194）×10^-3 mm²/s（n=17）,86.7%（13/15）TIC为Ⅱ型。结论: 绝大部分颌面部AciCC位于腮腺。常规MRI显示,AciCC形态学上与良性肿瘤较难鉴别。功能成像ADC值较良性肿瘤低,TIC曲线类型多为Ⅱ型。将形态学与功能成像相结合,可提高该病的诊断准确率。

关键词: 腮腺, 腺泡细胞癌, 磁共振成像, 功能成像

Abstract: PURPOSE: To describe the MRI features of acinar cell carcinoma of parotid gland (AciCC) and to evaluate the diagnostic value of MR functional imaging. METHODS: A total of 269 cases of maxillofacial AciCC confirmed by surgery and pathology were analyzed. Among them, nineteen subjects with AciCC in the parotid gland underwent preoperative MRI examination (non-enhanced scan for one case, enhanced scan for 18 cases), seventeen patients underwent diffusion-weighted imaging scan, and 15 patients underwent dynamic contrast-enhanced scan. MRI findings of 19 patients were retrospectively analyzed. The lesion size, location, morphology, margin, internal composition, enhancement pattern and functional imaging characteristics were analyzed. SPSS 25.0 software package was used for statistical analysis. RESULTS: Among 269 cases of maxillofacial AciCC, there were 108 males and 161 females, male: female = 1:1.49, aged from 4 to 89 years, with a mean age of (45.95±17.33) years. 84.4% (227/269) were located in the parotid gland. On MRI images, 78.9% (15/19) had well-defined margin, 57.9% (11/19) were round or oval, and 36.8% (7/19) were lobed nodules. One case had irregular morphology and peripheral invasion. The range of maximum diameter was 6-56 mm, averaging (24.8±15.3) mm. Internal composition showed 57.9% (11/19) were cystic solid, 42.1% (8/19) were solid, 31.6% (6/19) had bleeding. T2-weighted MRI showed 52.6% (10/19) with envelope structure, 15.8% (3/19) with low signal separation inside, 38.9%(7/18) had uniform enhancement, and 61.1%(11/18) had uneven enhancement. Functional imaging showed the mean ADC value of tumor was (1.026±0.194)×10^-3 mm²/s(n=17). 86.7%(13/15) TIC was type Ⅱ. CONCLUSIONS: Most maxillofacial AciCC are located in the parotid gland. It is difficult to distinguish AciCC from benign tumors with conventional MRI in morphology. The ADC value of AciCC is lower than that of benign tumors, and the type of TIC curve is mostly type Ⅱ. Combination of morphology and functional imaging can improve the diagnostic accuracy of this disease.

Key words: Parotid gland, Acinic cell carcinoma, Magnetic resonance image, Functional imaging

中图分类号:

R739.8

肖华, 陶晓峰, 朱文静, 陈倩倩. 19例腮腺腺泡细胞癌的MRI影像表现分析[J]. 上海口腔医学, 2022, 31(3): 322-326.

XIAO Hua, TAO Xiao-feng, ZHU Wen-jing, CHEN Qian-qian. MRI findings of parotid acinic cell carcinoma in 19 consecutive cases[J]. Shanghai Journal of Stomatology, 2022, 31(3): 322-326.

参考文献

[1] Spiro RH, Huvos AG, Strong EW.Acinic cell carcinoma of salivary origin. a clinicopathologic study of 67 cases[J]. Cancer,1978, 41(3): 924-935.
[2] EI-Naggar AK, Chan JKC, Grandis JR, et al.WHO classification of head and neck tumours[M]. 4th Ed. IARC: Lyon, 2017: 166-167.
[3] Suh SI, Seol HY, Kim TK, et al.Acinic cell carcinoma of the head and neck: radiologic-pathologic correlation[J]. J Comput Assist Tomogr, 2005, 29(1): 121-126.
[4] Ariji Y, Maeda H, Shimozato K, et al.Imaging features of acinic cell carcinoma: three case reports and a review of the literature[J]. Oral Radiol, 2004, 20(1): 22-31.
[5] Sakai O, Nakashima N, Takata Y, et al.Acinic cell carcinoma of the parotid gland: CT and MRI[J]. Neuroradiology, 1996, 38(7): 675-679.
[6] Buhas CL, Rosca E, Mutiu G, et al.Acinic cell carcinoma of minor salivary glands-case report[J]. Rom J Morphol Embryol, 2017, 58(3): 1003-1007.
[7] Yabuuchi H, Matsuo Y, Kamitani T, et al.Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?[J]. Radiology, 2008, 249(3): 909-916.
[8] 赵志国, 高丹, 王瑾, 等. 896例腮腺肿瘤临床回顾分析[J]. 上海口腔医学, 2017, 26(6): 605-609.
[9] Buxton RW, Maxwell JH, French AJ.Surgical treatment of epithelial tumors of the parotid gland[J]. Surg Gynecol Obstet, 1953, 97(4): 401-416.
[10] Hoffman HT, Karnell LH, Robinson RA, et al.National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma[J]. Head Neck, 1999, 21(4): 297-309.
[11] Buiret G, Céruse P, Ramadeet A, et al.Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2012, 129(2): 111-114.
[12] Gomez DR, Katabi N, Zhung J, et al.Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland[J]. Cancer, 2009, 115(10): 2128-2137.
[13] Wahlberg P, Anderson H, Biorklund A, et al.Carcinoma of the parotid and submandibular glands-a study of survival in 2465 patients[J]. Oral Oncol, 2002, 38(7): 706-713.
[14] Kashiwagi N, Nakatsuka SI, Murakami T, et al.MR imaging features of mammary analogue secretory carcinoma and acinic cell carcinoma of the salivary gland: a preliminary report[J]. Dentomaxillofac Radiol, 2018, 47(5): 20170218.
[15] Kuwabara H, Yamamoto K, Terada T, et al.Hemorrhage of MRI and immunohistochemical panels distinguish secretory carcinoma from acinic cell carcinoma[J]. Laryngoscope Investig Otolaryngol, 2018, 3(4): 268-274.
[16] Karaman CZ, Tanyeri A, Ozgur R, et al.Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results[J]. Dentomaxillofac Radiol, 2021, 50(4): 20200391.
[17] Yamamoto T, Kimura H, Hayashi K, et al.Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings[J]. Neuroradiology, 2018, 60(8): 803-812.
[18] Tao X, Yang G, Wang P, et al.The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours[J]. Dentomaxillofac Radiol, 2017, 46(6): 20160434.
[19] Okahara M, Kiyosue H, Hori Y, et al.Parotid tumors: MR imaging with pathological correlation[J]. Eur Radiol, 2003, 13(Suppl 4): L25-33.

19例腮腺腺泡细胞癌的MRI影像表现分析

MRI findings of parotid acinic cell carcinoma in 19 consecutive cases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	姚清婷, 吴言辉, 刘少华, 许辉, 李军, 石亮. 电离辐射对大鼠腮腺旁细胞分泌途径损伤及紧密连接蛋白claudin-4的影响[J]. 上海口腔医学, 2022, 31(4): 359-366.
[2]	陈旭, 徐丽丽, 蔡斌. 弹响消除试验在颞下颌关节可复性关节盘前移位诊断中的信度和效度分析[J]. 上海口腔医学, 2021, 30(6): 629-633.
[3]	徐万林, 朱云, 卢浩, 丁继平, 姚原, 刘胜文, 张陈平, 杨雯君. 腮腺区广泛型复发性多形性腺瘤的面神经处理及术后放疗经验：附10例报告[J]. 上海口腔医学, 2021, 30(6): 667-672.
[4]	齐鑫, 谢敬生, 王梓欣. 腮腺保留式调强放疗对唾液组成、流量及口干的影响[J]. 上海口腔医学, 2020, 29(4): 396-399.
[5]	常攀辉, 艾克白尔·吐日洪, 李崴嵬. mTOR及Tfr1 mRNA在腮腺黏液表皮样癌组织中的表达及与预后的关系[J]. 上海口腔医学, 2019, 28(5): 499-503.
[6]	郑重阳, 张新宇, 曹锐, 刘浏, 胡永杰. 超声刀辅助下腮腺良性肿瘤功能性包膜外切除术的临床效果评价[J]. 上海口腔医学, 2019, 28(4): 402-407.
[7]	胡赟, 张艳胜. CD44v6与COX-2在腮腺多形性腺瘤及癌在多形性腺瘤中的表达及临床意义[J]. 上海口腔医学, 2019, 28(4): 412-416.
[8]	高明华, 尹雪莱, 胡永杰, 盛美春, 王忠华, 郑重阳, 张新宇, 吴海威. 52例腮腺区神经鞘瘤临床治疗及预后分析[J]. 上海口腔医学, 2018, 27(4): 411-414.
[9]	张蔚蒨, 龚霞, 熊屏. 超声弹性成像在干燥综合征唾液腺病变中的应用价值[J]. 上海口腔医学, 2018, 27(1): 73-78.
[10]	赵志国, 高丹, 王瑾, 张力平. 896例腮腺肿瘤临床回顾分析[J]. 上海口腔医学, 2017, 26(6): 605-609.
[11]	高振然, 马松波, 张国琴. C形小切口治疗腮腺后下极良性肿瘤48例临床分析[J]. 上海口腔医学, 2017, 26(6): 666-668.
[12]	刘华, 周驰, 纪均. 不同剂量右美托咪定对腮腺手术患者全麻苏醒质量的影响[J]. 上海口腔医学, 2016, 25(3): 368-372.
[13]	王智明，叶明，杨东升，马颖，苏欣，张维庆，潘遥，关乔丹. 45例腮腺囊肿临床病理分析[J]. 上海口腔医学, 2016, 25(2): 199-203.
[14]	陈蔚华，裴婧，卓夏阳. 腮腺腺鳞癌1例报告及文献复习[J]. 上海口腔医学, 2015, 24(6): 763-765.
[15]	林倩, 李俊来, 王节, 张舜欣, 刘萃, 曹晓林. 超声检查在IgG4相关唾液腺病变诊断中的应用[J]. 上海口腔医学, 2014, 23(6): 744-748.